JPRN-jRCT1030220502
Not yet recruiting
未知
Identification of novel biomarkers for the diagnosis and treatment of renal pelvis and ureteral cancer using urinary exosomes.
Hayakawa Nozomi0 sites250 target enrollmentDecember 9, 2022
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Cancer of the renal pelvis and ureter
- Sponsor
- Hayakawa Nozomi
- Enrollment
- 250
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients who have visited the outpatient urology clinic, who are at least 20 years old, and whose urine can be collected.
Exclusion Criteria
- •1\) Patients undergoing treatment for malignant diseases in other departments
- •2\) Patients who are judged by the investigator to be unsuitable as subjects
- •3\) Patients who have indicated that they will not cooperate in this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Research to find new indicators for diagnosis and treatment of bladder cancer using exosomes in urineJPRN-UMIN000045726St.Marianna University School of Medicine420
Recruiting
Not Applicable
Discovery of proteins that differentiate health and disease around dental implantsPeri-ImplantitisE06.780.346.593RBR-99xvpphniversidade Estadual de Maringá
Recruiting
Not Applicable
Discovery of new biomarkers related with disease progression in hardly curable malignant hematologic diseasesNeoplasmsKCT0000414Seoul National University Hospital200
Recruiting
Not Applicable
The discovery of new biomarkers for the diagnosis of early hepatocellular carcinoma by liquid biopsyKCT0007938Soon Chun Hyang University70
Completed
Not Applicable
Research for new biomarker about diagnosis and evaluation of disease condition for inflammatory bowel disease (IBD).Inflammatory bowel diseaseJPRN-UMIN000017831Kyoto Prefectural University of Medicine400